The global Personal Health Record Software Market size is expected to reach USD 14.87 million by 2028, growing at a CAGR of 9.9% over the forecast period, according to a new report by Grand View Research, Inc. High acceptance of advanced technologies, growing demand for centralizing, and streamlining of healthcare information, rising awareness among patients for medical information storage and management, and increasing government initiatives will support the market growth during the forecast period.
For instance, in October 2019, The Union Ministry of Health and Family Welfare, Government of India developed an app, ‘My Health Record’, which permits users to store their past prescriptions, detailed health profile, lab records & diagnoses at one platform and share it with medical specialists when required. The COVID-19 has toppled the way of work and life, enforcing healthcare groups to share individual’s medical records in a format that is meaningful and easily available. The Department of Health and Human Services Office of the National Coordinator for Health Information Technology, together with the Centers for Medicare & Medicaid Services, issued two new rules to come into force in April 2021. One rule requires healthcare groups to make health record data available electronically through broadly-used technical standards. While the other forbids “information blocking,” where healthcare groups place excessive practical, cost, and technical barriers to the sharing of health information. The North American region held the largest revenue share of over 55% in 2020 owing to the government initiatives for eHealth and an increased need to follow regulatory guidelines and curtail the rising healthcare costs. The European region held the second-largest market share in 2020 owing to the decreased cost of care and prediction of a possible medical emergency. Key players are investing in many strategic initiatives, such as acquisitions, mergers, partnerships, and product launches, among others to maintain a competitive edge in the market. For instance, in March 2020, Knapsack Health launched a free Personal Health Record for individuals, families, and caretakers. Related Press Release@ Personal Health Record Software Market Report Personal Health Record Software Market Report Highlights
0 Comments
Diaphragm Pacing Therapy System Market Size is Expected to Experience a CAGR of 4.6% till 202810/27/2021 The global Diaphragm Pacing Therapy System Market size is expected to reach USD 11.5 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.6% from 2021 to 2028. Some of the factors contributing to the market growth are the upsurge in the prevalence of breathing disorders including sleep apnea, the rise in spinal cord injuries, and amyotrophic lateral sclerosis.
The attributes such as facilitating normal breathing and better speech patterns, movement convenience, ease at eating and drinking, improved sense of smell, and silent functioning of a breathing pacemaker are boosting the adoption of the therapy systems. Moreover, it reduces the dependence on mechanical ventilators and the risk of upper airway infections such as ventilator-associated pneumonia. The Covid-19 pandemic has further increased the demand for ventilation requirements to cater to the infected patients requiring respiratory care. In April 2020, the diaphragm pacing therapy system by Lungpacer Medical, Inc. received the FDA Emergency Use Authorization (EUA) approval to assist the weaning COVID patients. Related Press Release@ Diaphragm Pacing Therapy System Market Report Diaphragm Pacing Therapy System Market Report Highlights
The global Dental Services Market size is expected to reach USD 554.5 billion by 2028, based on a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.4% from 2021 to 2028. The marketing efforts to commercialize dental practices including education camps and online campaigns are contributing to the adoption of dental services. The rapid urbanization around the world, constant economic growth, and the rising disposable income of people have contributed to the relatively steady growth of the market. In addition, per capita consumption expenditure on healthcare services is likely to significantly increase in the coming years.
The market for dental services was severely impacted due to the COVID-19 pandemic as the clinics were closed due to the imposed social distancing. In March 2020, the American Dental Association (ADA) issued guidelines to postpone elective dental procedures. Only the emergency procedures were allowed to carry out during the early phase of the pandemic. In April 2021, Mills Administration in partnership with Northeast Delta Dental launched Maine Veterans’ Dental Network. It was launched officially in May 2021 and provides services to Maines’s veterans who were not able to afford it. In July 2021, Geyer Dental Group updated their Dental Crown Repair/Cap Fitting Restorative Dentistry service for the people in Greater St. Louis. The practice offers periodontal, cosmetic, and restorative dentistry. Related Press Release@ Dental Services Market Report Dental Services Market Report Highlights
![]() The global Ophthalmic Photocoagulator Market size is expected to reach USD 213.2 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.7% from 2021 to 2028. The global influence of COVID-19 on eye health and the rise in the incidence of increasing ocular diseases, such as diabetic retinopathy and age-related macular edema, are the key factors fuelling the market growth. The growing elderly population and the increasing prevalence of diabetes-related blindness are also projected to fuel the market growth. Various eye diseases are quite frequent in the geriatric population. The National Institute on Aging (NIA) estimated that the elderly population would reach 72 million people by 2030. Diabetic retinopathy has become more common as the diabetic epidemic has spread throughout the world. Individuals' average time spent on a digital screen has risen, resulting in a variety of eye-related pain and disorders. The growing need for ophthalmic photocoagulator, which is cost-effective, painless, and non-invasive, is expected to drive the market. Major market participants are adopting various methods, such as M&A, cooperation, and partnerships, to maintain competitiveness in the industry. For instance, Quantel Medical has acquired Ellex, which includes the company's laser technology solutions. The WHO is currently working on a package of eye care treatments for a variety of eye disorders, with epidemiology and field professionals providing input. Countries will be able to utilize these tools to help them make decisions about service inclusion, delivery methods, and resource implications. COVID-19 is expected to negatively impact the market growth. This is due to increasing delay in routine ophthalmic procedures due to the growing risk of infection. Additionally, people suffering from ophthalmic disorders are not opting for diagnostic and treatment options to avoid the visit to medical settings due to the spread of the virus. Hence, this is expected to hinder the market growth. Related Press Release@ Ophthalmic Photocoagulator Market Report Ophthalmic Photocoagulator Market Report Highlights
![]() The global Lateral Flow Assays Market size is expected to reach USD 8.51 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.9% from 2021 to 2028. Abbott Laboratories, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, Bio-rad Laboratories, Inc., Biomérieux SA are some key industry participants. Major drivers of the market include an increase in the prevalence of infectious diseases, a rise in government initiatives to curb infectious and chronic diseases, a rise in demand for point of care testing, and strategic mergers & acquisitions among others. Continuous strategic initiatives by leading and emerging players to develop and launch advanced products are anticipated to significantly support the market growth. For instance, in January 2021, U.K.-based Sensyne Health launched MagnifEye, a novel smartphone app that utilizes deep machine learning AI to automate the accurate reading of lateral flow diagnostic tests. Additionally, in March 2021, IUL SA, a Spain-based lateral flow products manufacturer, introduced its new lateral flow reader, iPeak+. In addition, a rise in mergers and collaborations by market players is anticipated to facilitate access to novel lateral flow technologies. In April 2021, DiaSorin, an Italian biotechnology company, entered into a strategic collaboration with Lumos Diagnostics to launch its new immunoassay PoC platform, LIAISON IQ. This platform will be Diasorin’s newest generation CLIA-waived immunoassay PoC platform for the lateral flow readers market. Moreover, in August 2019, Qiagen signed a strategic distribution agreement with ViroGates A/S - a Denmark-based healthcare company - to increase access of its lateral flow reader to other geographies. A rise in the prevalence of infectious diseases, including the outbreak of COVID-19, and an increase in government initiatives to curb COVID-19, HIV, and other communicable diseases are anticipated to create significant demand for lateral flow devices. According to the U.S. Department of Health & Human Services, the U.S. government has formed the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) that works towards preventing, early detection, and responding to new as well as existing risks related to AIDS and HIV. Additionally, the National Institute of Health (NIH) has several programs aimed to increase research-related activities pertaining to HIV/AIDS treatment and management globally. NIH engages in research related to prevention, diagnosis, treatment, and precaution measures to curb HIV infection. Related Press Release@ Lateral Flow Assays Market Report Lateral Flow Assays Market Report Highlights
The global Blood Ketone Meter Market size is expected to reach USD 501.5 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.7% from 2021 to 2028. Reimbursement scenario and favorable health insurance are significant factors that are anticipated to surge the demand for blood ketone meters. Technological advancements in Type 1 Diabetes care lead to the increasing preference for automated devices among individuals that aid in reducing disease burden.
Diabetes prevalence is increasing worldwide, due to which the number of hospital admissions with patients suffering from complications, including diabetic ketoacidosis (DKA), is also rising. DKA is a severe and life-threatening complication of diabetes. This disease is more common among people with type 1 diabetes and affects around 30 million people across the U.S. Lifestyle changes, rapid urbanization, increased life expectancy, and dietary changes are the major causes of diabetes. The rise in the geriatric and obese population across the globe is expected to boost the growth of the market. As per the WHO, by 2050, the world’s population aged 60 years and above is likely to reach 2 billion by 2050. Similarly, as per the American Diabetes Association, one-third of U.S. adults aged 65 and above had diabetes in 2017. Thus, a rise in the number of adults with diabetes is anticipated to boost the demand for blood ketone meters during the forecast period. An increasing number of hospital admissions owing to the rising cases of DKA in developing as well as developed nations are estimated to foster the market growth. According to a Diabetes Care Study, DKA causes approximately 200,000 hospitalizations each year in the U.S. Rising hospital admissions eventually lead to an increase in healthcare costs, thereby fueling the market growth. Related Press Release@ Blood Ketone Meter Market Report Blood Ketone Meter Market Report Highlights
Dental Caries Detectors Market by Dentsply Sirona, Kavo Dental, Quantum Dental Technologies, Inc.10/25/2021 The global Dental Caries Detectors Market size is expected to reach USD 512.0 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.9% from 2021 to 2028. Dental caries detection devices assist in evaluating enamel structure for conditions like caries or micro-fractures in the tooth before sealant placement. Caries detection devices assist in the primary detection of dental caries, which might lead to early diagnosis by the dental professional. Factors like the increasing prevalence of caries, increasing awareness about oral health, and rising advancement in dental diagnostic are expected to propel the market growth.
Dental caries is the most prevalent and preventable dental condition, which if identified early, can be treated by non-invasive techniques. According to the WHO, as of 2017, around 2.3 billion people suffer from caries of permanent teeth and more than 530 million children suffer from caries of primary teeth. Changing lifestyle, high sugar consumption, and less awareness about oral hygiene in low- and middle-income countries are the most common causes for the prevalence of caries. Moreover, technological advancement in caries detection devices that assures high accuracy and sensitivity for diagnosing caries lesions is expected to propel market growth. For instance, Digital Imaging Fiber Optic Trans-illumination technique has an accuracy of 90% and the images can be stored digitally by the professionals, assisting in providing quality treatment to the patient. In the light of COVID-19, the global market was hampered as the footfall of patient appointments for surgical treatments was temporarily suspended. However, since the governments in many countries have allowed resuming elective surgical procedures, clinics have also started orthodontic procedures again by adhering to strict Covid-19 protocols. Moreover, many dentists believe that there will be a surge in oral care and dental treatments post-Covid-19 crisis and this is expected to propel the market growth. Related Press Release@ Dental Caries Detectors Market Report Dental Caries Detectors Market Report Highlights
Clinical Trial Kits Market - Future Trends, Revenue Growth & Leading Players, Forecast To 202810/25/2021 The global Clinical Trial Kits Market size is anticipated to reach USD 2.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.5% from 2021 to 2028. The factors driving market expansion include globalization of clinical trials, increasing demand for remote services, and rising clinical trial complexity.
Remote clinical trial services are becoming increasingly essential in terms of patient retention, satisfaction, and safety. To enhance their capabilities, pharmaceutical companies have created a relationship with global logistics partners to provide direct-to-patient services. These services provide participants with the flexibility and convenience of participating in the trials while remaining at home. COVID-19 pandemic has affected the market which resulted in slowing down the trial process. The COVID-19 pandemic is rapidly boosting advances in medical practices that allow people to connect with the healthcare system remotely. This effort of examining the patients at their homes has raised interest in at-home sample collection and testing. Such services offer convenience and minimize potential exposure to SARS-CoV-2. Companies began to move to provide direct-to-consumer testing digital services. More aspects of the testing process, from test ordering to sample collection, are already making their way into patients' homes. Besides, regulatory authorities have instantly given sponsors guidelines to resolve issues that have arisen during ongoing clinical studies. Changes such as the use of telemedicine, the elimination of non-essential visits and laboratory assessments, as well as diagnostic testing and sample collection, have allowed many studies to continue while ensuring patient safety during the pandemic. Related Press Release@ Clinical Trial Kits Market Report Clinical Trial Kits Market Report Highlights
The global Active Pharmaceutical Ingredients CDMO Market size is expected to reach USD 136.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2021 to 2028. Increasing pharmaceutical R&D investment, patent expirations, and rise in demand for generic drugs and biologic innovation are the factors driving the market.
The growth of small molecules, rising Active Pharmaceutical Ingredient (API) complexity, and the need to reduce costs are factors contributing to the rapid expansion of outsourcing services in the pharmaceutical sector. Only a few companies have achieved global reach and scale in the Contract Development and Manufacturing Organization (CDMO) sector, which is still fragmented. Besides, many companies are providing one-stop-shop solutions as an integrated source of APIs and formulations. However, due to the COVID-19 pandemic, governments worldwide have opted to boycott APIs made in China. Due to government-imposed lockdown limitations in China, 44 firms were declared non-operational during the pandemic. As a consequence, various countries have launched programs to develop their own APIs, and countries across the EU have re-evaluated their healthcare models in order to combat the virus and ensure a steady supply of APIs. COVID-19 has placed unprecedented expectations on API makers, as evidenced by the substantial increase in demand for medications required to manage critically ill patients on mechanical ventilation. As a result, the sudden need to rapidly increase production has emphasized the need for adaptability for API CDMOs in maintaining drug supply, with some companies proving better able to withstand the pressures of quick scale up than others. Related Press Release@ Active Pharmaceutical Ingredients CDMO Market Report Active Pharmaceutical Ingredients CDMO Market Report Highlights
The global Pharmaceutical Cleaning Validation Market size is expected to reach USD 22.8 billion by 2028 and is expected to expand at a CAGR of 5.5% over the forecast period, according to a new report by Grand View Research, Inc. Global pharma companies are focusing their efforts on their R&D facilities and pushing for innovation to boost drug discovery and development.
This new wave of transformation in pharma manufacturing is being supported by several scientific breakthroughs. The U.S. FDA is supporting these advancements by opting for a more pragmatic approach to regulation which assists the sector in accelerating the throughput of therapeutics and lifesaving medicines. The rising demand for medicinal drugs is contributing to the surge in demand for cleaning validation to ensure drug safety, monitor residues, impurities, and other potential contaminants, which could cause cross-contamination from the previous manufactured batch. Since cleaning validation makes an integral process in pharmaceutical manufacturing processes, the need for spreading awareness and educating market players of the same is growing. The International Society for Pharmaceutical Engineering (ISPE) to spread awareness on drug discovery, approvals, and inspection management organized its inaugural ISPE APAC Pharmaceutical Manufacturing Conference in September 2019 and its second edition in September 2020, wherein, one of the key topics covered were cleaning validation and cross-contamination control. The regulatory standards about the adoption of cleaning validation in drug manufacturing are established and revised majorly by the U.S. Food and Drug Administration (U.S. FDA) and the European Medicines Agency (EMA). The EMA is a frontrunner when it comes to developing risk-based cleaning validation standards to prevent cross-contamination in shared manufacturing facilities. Pharmaceutical Inspection Co-operation Scheme (PIC/S) followed EMA’s lead and laid down its own set of new guidelines in association with cleaning validation to prevent cross-contamination and establish Health-Based Exposure Limits (HBEL) in share manufacturing facilities in June 2018. Next, an AIDE-MEMOIRE was published to outline the checklist that regulators would be meticulously inspecting. The abovementioned factors have resulted in boosting the demand for cleaning validation for drug manufacturing companies and have positively impacted the growth of the market. Since the pharmaceutical industry is more crucial compared to other industries and non-compliance could lead to negative consequences on human health, the regulatory standards are more stringent for the companies. Moreover, key players are focused on developing more advanced analytical testing products to improve procedures. Companies are either solely or partnering with other key players to accelerate product development. For instance, in December 2020, Suez launched their latest Sievers TOC online analyzer, the M500 for the life science and pharmaceutical industries. This advanced analyzer enhances efficiency by cutting down analysis time by 50% and includes digital upgrades like Wi-Fi capabilities, enhanced security features to protect data integrity, and improved data transfer. Similarly, in August 2020 HORIBA Ltd and Shimadzu Corporation entered a strategic collaboration to develop and distribute LC-Raman analytical and measuring instruments using the combined resources and capabilities of the two companies. Such initiatives are expected to boost the growth and development of the market during the forecast period. Related Press Release@ Pharmaceutical Cleaning Validation Market Report Pharmaceutical Cleaning Validation Market Report Highlights
|
Archives
October 2023
|